StockData
Pharming Group N.V. logo

Pharming Group N.V. (PHAR) stock

PHARNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on Apr 2, 2026Score 8/30
$12.48+0.42 (+3.51%)

Close on Nov 18, 2026Market cap $875.92MP/E 312.1Yield –

Pharming net income

Net income is the profit left for shareholders after every expense, interest and tax.

For fiscal 2025 it was $2.85M.

Annual net income

PeriodPeriod endValueChange
FY2025Dec 31, 2025$2.85M–
FY2024Dec 31, 2024-$11.84M–
FY2023Dec 31, 2023-$10.55M–

More Pharming figures

See a number that looks wrong?